» Articles » PMID: 35677162

ERH Gene and Its Role in Cancer Cells

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Jun 9
PMID 35677162
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a major public health problem worldwide. Studies on oncogenes and tumor-targeted therapies have become an important part of cancer treatment development. In this review, we summarize and systematically introduce the gene enhancer of rudimentary homolog (ERH), which encodes a highly conserved small molecule protein. ERH mainly exists as a protein partner in human cells. It is involved in pyrimidine metabolism and protein complexes, acts as a transcriptional repressor, and participates in cell cycle regulation. Moreover, it is involved in DNA damage repair, mRNA splicing, the process of microRNA hairpins as well as erythroid differentiation. There are many related studies on the role of ERH in cancer cells; however, there are none on tumor-targeted therapeutic drugs or related therapies based on the expression of ERH. This study will provide possible directions for oncologists to further their research studies in this field.

Citing Articles

Unveiling as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis.

Chang C, Chen L, Chen Y, Huang C, Yu C, Lin V Biomedicines. 2025; 13(1).

PMID: 39857609 PMC: 11760481. DOI: 10.3390/biomedicines13010025.


Large-scale map of RNA-binding protein interactomes across the mRNA life cycle.

Street L, Rothamel K, Brannan K, Jin W, Bokor B, Dong K Mol Cell. 2024; 84(19):3790-3809.e8.

PMID: 39303721 PMC: 11530141. DOI: 10.1016/j.molcel.2024.08.030.


Epigenetic dysregulated long non-coding RNAs in renal cell carcinoma based on multi-omics data and their influence on target drugs sensibility.

Wang J, Dou P, Sun Y, Zheng J, Wu G, Liu H Front Genet. 2024; 15:1406150.

PMID: 39156959 PMC: 11327069. DOI: 10.3389/fgene.2024.1406150.


Multifaceted Proteome Analysis at Solubility, Redox, and Expression Dimensions for Target Identification.

Saei A, Lundin A, Lyu H, Gharibi H, Luo H, Teppo J Adv Sci (Weinh). 2024; 11(38):e2401502.

PMID: 39120068 PMC: 11481203. DOI: 10.1002/advs.202401502.


Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma.

Tsai Y, Wu K, Huang Y, Wu Y, Chang C, Chang Y Mol Med Rep. 2023; 29(1).

PMID: 37997813 PMC: 10704564. DOI: 10.3892/mmr.2023.13132.


References
1.
Tashiro S, Asano T, Kanoh J, Ishikawa F . Transcription-induced chromatin association of RNA surveillance factors mediates facultative heterochromatin formation in fission yeast. Genes Cells. 2013; 18(4):327-39. DOI: 10.1111/gtc.12038. View

2.
Lukasik A, Uniewicz K, Kulis M, Kozlowski P . Ciz1, a p21 cip1/Waf1-interacting zinc finger protein and DNA replication factor, is a novel molecular partner for human enhancer of rudimentary homolog. FEBS J. 2007; 275(2):332-40. DOI: 10.1111/j.1742-4658.2007.06203.x. View

3.
Schneider K, Wells B, Dolan L, Roberts K . Structural and genetic analysis of epidermal cell differentiation in Arabidopsis primary roots. Development. 1997; 124(9):1789-98. DOI: 10.1242/dev.124.9.1789. View

4.
Weng M, Lee J, Wei S, Li Q, Shahamatdar S, Hsu D . Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A. 2012; 109(52):E3659-67. PMC: 3535619. DOI: 10.1073/pnas.1207673110. View

5.
Zhang D, Chu Y, Song K, Chen Y, Liu W, Lv T . Knockdown of enhancer of rudimentary homolog inhibits proliferation and metastasis in ovarian cancer by regulating epithelial-mesenchymal transition. Biomed Pharmacother. 2020; 125:109974. DOI: 10.1016/j.biopha.2020.109974. View